These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12532558)

  • 1. Drug-induced hepatotoxicity.
    Podda M; Benetti A
    Ann Ital Med Int; 2002; 17(4):213-4. PubMed ID: 12532558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholestatic hepatitis from ticlopidine].
    Torrano Larrión F
    Aten Primaria; 1999 Jun; 24(2):115. PubMed ID: 10432757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxic hepatitis by ticlopidine. Three new cases].
    Artímez ML; Fernández E; Rodríguez M; González M; Rodrigo L
    Rev Esp Enferm Dig; 1997 Oct; 89(10):796-7. PubMed ID: 9424112
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ticlopidine-induced cholestatic hepatitis. A case report].
    López P; Castiella A; Bujanda L; Arenas JI
    Rev Esp Enferm Dig; 1995 Oct; 87(10):735-7. PubMed ID: 8519541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of drug induced hepatitis and pancreatitis].
    Shimizu A; Koyama M; Miyazaki K; Tagawa S; Takase K; Nakano T; Tameda Y; Kosaka Y
    Nihon Shokakibyo Gakkai Zasshi; 1997 May; 94(5):351-5. PubMed ID: 9170884
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature.
    Grieco A; Vecchio FM; Greco AV; Gasbarrini G
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):713-5. PubMed ID: 9744703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Post-infantile giant cell hepatitis. Clinical and histological response to immunosuppressive therapy].
    Pittau S; Morelli S; Venturini E; Boldorini R; Sartori M
    Recenti Prog Med; 1998 Mar; 89(3):126-9. PubMed ID: 9586424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholestasis from ticlopidine: two clinical cases].
    Varvello L; Arnò C; Coggiola M; Ramassotto E; Pascale C
    Ann Ital Med Int; 2002; 17(4):252-5. PubMed ID: 12532564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable dalteparin-induced hepatotoxicity in a man with alpha-1-antitrypsin deficiency.
    Levinson P; Glaumann H; Söderberg M
    J Clin Pharmacol; 2012 Nov; 52(11):1764-7. PubMed ID: 22167567
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early hepatopathy induced by ticlopidine].
    Blanco JR; Márquez M; Salcedo J; Zabala M
    An Med Interna; 2001 Jan; 18(1):48-9. PubMed ID: 11387849
    [No Abstract]   [Full Text] [Related]  

  • 11. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine-induced hepatitis.
    Chen LK; Hsieh BH; Chen WC; Tsai ST; Hou MC
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):59-63. PubMed ID: 11310373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ticlopidine-induced cholestatic hepatitis].
    Miras Parra FJ; Gómez Jiménez FJ; García Contreras T; Valverde Romera M
    Rev Esp Enferm Dig; 1995 May; 87(5):414-5. PubMed ID: 7626305
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ticlopidine-induced hepatitis. Report of a new case].
    Rivera Vaquerizo P; Solís García del Pozo J; Villanueva Hernández P
    An Med Interna; 2002 Feb; 19(2):99-100. PubMed ID: 11989110
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new drug responsible for microvesicular steatosis: ticlopidine].
    Remy AJ; Heran B; Galindo G; Tapie C; Khemissa F; Larrey D
    Gastroenterol Clin Biol; 1999 Jan; 23(1):151-2. PubMed ID: 10219621
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholestatic hepatitis associated with ticlopidine].
    Bruguera M
    Gastroenterol Hepatol; 1997 Mar; 20(3):163-4. PubMed ID: 9162540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis due to ticlopidine: a new case].
    Sondag D; Bader R; Claude P; Schreiber M
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):40-1. PubMed ID: 8442652
    [No Abstract]   [Full Text] [Related]  

  • 18. Cholestatic hepatitis: ticlopidine suspected.
    Roy L; Plante MA; Perreault H; Biron P
    Therapie; 1995; 50(6):593-4. PubMed ID: 8745964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver toxicity from heparin].
    Barreiro López B; Canet JJ; Ochoa de Echaguen Aguilar A
    An Med Interna; 2000 Mar; 17(3):164. PubMed ID: 10804648
    [No Abstract]   [Full Text] [Related]  

  • 20. Ticlopidine-induced granulomatous hepatitis.
    Ruiz-Valverde P; Zafon C; Segarra A; Ribera R; Piera L
    Ann Pharmacother; 1995 Jun; 29(6):633-4. PubMed ID: 7663041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.